547 related articles for article (PubMed ID: 25872790)
1. Safety and efficacy of colistin versus meropenem in the empirical treatment of ventilator-associated pneumonia as part of a macro-project funded by the Seventh Framework Program of the European Commission studying off-patent antibiotics: study protocol for a randomized controlled trial.
Rosso-Fernández C; Garnacho-Montero J; Antonelli M; Dimopoulos G; Cisneros JM;
Trials; 2015 Mar; 16():102. PubMed ID: 25872790
[TBL] [Abstract][Full Text] [Related]
2. Colistin versus meropenem in the empirical treatment of ventilator-associated pneumonia (Magic Bullet study): an investigator-driven, open-label, randomized, noninferiority controlled trial.
Cisneros JM; Rosso-Fernández CM; Roca-Oporto C; De Pascale G; Jiménez-Jorge S; Fernández-Hinojosa E; Matthaiou DK; Ramírez P; Díaz-Miguel RO; Estella A; Antonelli M; Dimopoulos G; Garnacho-Montero J;
Crit Care; 2019 Nov; 23(1):383. PubMed ID: 31779711
[TBL] [Abstract][Full Text] [Related]
3. Multicentre open-label randomised controlled trial to compare colistin alone with colistin plus meropenem for the treatment of severe infections caused by carbapenem-resistant Gram-negative infections (AIDA): a study protocol.
Dickstein Y; Leibovici L; Yahav D; Eliakim-Raz N; Daikos GL; Skiada A; Antoniadou A; Carmeli Y; Nutman A; Levi I; Adler A; Durante-Mangoni E; Andini R; Cavezza G; Mouton JW; Wijma RA; Theuretzbacher U; Friberg LE; Kristoffersson AN; Zusman O; Koppel F; Dishon Benattar Y; Altunin S; Paul M;
BMJ Open; 2016 Apr; 6(4):e009956. PubMed ID: 27098822
[TBL] [Abstract][Full Text] [Related]
4. Impact of the duration of antibiotics on clinical events in patients with Pseudomonas aeruginosa ventilator-associated pneumonia: study protocol for a randomized controlled study.
Bouglé A; Foucrier A; Dupont H; Montravers P; Ouattara A; Kalfon P; Squara P; Simon T; Amour J;
Trials; 2017 Jan; 18(1):37. PubMed ID: 28114979
[TBL] [Abstract][Full Text] [Related]
5. Empiric antibiotics pending bronchoalveolar lavage data in patients without pneumonia significantly alters the flora, but not the resistance profile, if a subsequent pneumonia develops.
Thakkar RK; Monaghan SF; Adams CA; Stephen A; Connolly MD; Gregg S; Cioffi WG; Heffernan DS
J Surg Res; 2013 May; 181(2):323-8. PubMed ID: 22906560
[TBL] [Abstract][Full Text] [Related]
6. Effect of aerosolized colistin as adjunctive treatment on the outcomes of microbiologically documented ventilator-associated pneumonia caused by colistin-only susceptible gram-negative bacteria.
Tumbarello M; De Pascale G; Trecarichi EM; De Martino S; Bello G; Maviglia R; Spanu T; Antonelli M
Chest; 2013 Dec; 144(6):1768-1775. PubMed ID: 23989805
[TBL] [Abstract][Full Text] [Related]
7. Colistin for the treatment of ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: a systematic review and meta-analysis.
Gu WJ; Wang F; Tang L; Bakker J; Liu JC
Int J Antimicrob Agents; 2014 Dec; 44(6):477-85. PubMed ID: 25199968
[TBL] [Abstract][Full Text] [Related]
8. GRam stain-guided Antibiotics ChoicE for Ventilator-Associated Pneumonia (GRACE-VAP) trial: rationale and study protocol for a randomised controlled trial.
Yoshimura J; Yamakawa K; Kinoshita T; Ohta Y; Morimoto T
Trials; 2018 Nov; 19(1):614. PubMed ID: 30409160
[TBL] [Abstract][Full Text] [Related]
9. Aerosolized plus intravenous colistin versus intravenous colistin alone for the treatment of ventilator-associated pneumonia: a matched case-control study.
Kofteridis DP; Alexopoulou C; Valachis A; Maraki S; Dimopoulou D; Georgopoulos D; Samonis G
Clin Infect Dis; 2010 Dec; 51(11):1238-44. PubMed ID: 20973727
[TBL] [Abstract][Full Text] [Related]
10. Clinical pulmonary infection score and a spot serum procalcitonin level to guide discontinuation of antibiotics in ventilator-associated pneumonia: a study in a single institution with high prevalence of nonfermentative gram-negative bacilli infection.
Wongsurakiat P; Tulatamakit S
Ther Adv Respir Dis; 2018; 12():1753466618760134. PubMed ID: 29506460
[TBL] [Abstract][Full Text] [Related]
11. How to treat VAP due to MDR pathogens in ICU patients.
Garnacho-Montero J; Corcia-Palomo Y; Amaya-Villar R; Martin-Villen L
BMC Infect Dis; 2014 Nov; 14():135. PubMed ID: 25430700
[TBL] [Abstract][Full Text] [Related]
12. Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj Hospital: etiology, clinical outcomes, and impact of antimicrobial resistance.
Werarak P; Kiratisin P; Thamlikitkul V
J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S126-38. PubMed ID: 20364567
[TBL] [Abstract][Full Text] [Related]
13. Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial.
Paul M; Daikos GL; Durante-Mangoni E; Yahav D; Carmeli Y; Benattar YD; Skiada A; Andini R; Eliakim-Raz N; Nutman A; Zusman O; Antoniadou A; Pafundi PC; Adler A; Dickstein Y; Pavleas I; Zampino R; Daitch V; Bitterman R; Zayyad H; Koppel F; Levi I; Babich T; Friberg LE; Mouton JW; Theuretzbacher U; Leibovici L
Lancet Infect Dis; 2018 Apr; 18(4):391-400. PubMed ID: 29456043
[TBL] [Abstract][Full Text] [Related]
14. Intravenous combined with aerosolised polymyxin versus intravenous polymyxin alone in the treatment of pneumonia caused by multidrug-resistant pathogens: a systematic review and meta-analysis.
Liu D; Zhang J; Liu HX; Zhu YG; Qu JM
Int J Antimicrob Agents; 2015 Dec; 46(6):603-9. PubMed ID: 26607337
[TBL] [Abstract][Full Text] [Related]
15. Prospective, comparative clinical study between high-dose colistin monotherapy and colistin-meropenem combination therapy for treatment of hospital-acquired pneumonia and ventilator-associated pneumonia caused by multidrug-resistant Klebsiella pneumoniae.
Abdelsalam MFA; Abdalla MS; El-Abhar HSE
J Glob Antimicrob Resist; 2018 Dec; 15():127-135. PubMed ID: 30010061
[TBL] [Abstract][Full Text] [Related]
16. Treatment of recurrent Stenotrophomonas maltophilia ventilator-associated pneumonia with doxycycline and aerosolized colistin.
Wood GC; Underwood EL; Croce MA; Swanson JM; Fabian TC
Ann Pharmacother; 2010 Oct; 44(10):1665-8. PubMed ID: 20736426
[TBL] [Abstract][Full Text] [Related]
17. Reinventing the wheel: Impact of prolonged antibiotic exposure on multidrug-resistant ventilator-associated pneumonia in trauma patients.
Lewis RH; Sharpe JP; Swanson JM; Fabian TC; Croce MA; Magnotti LJ
J Trauma Acute Care Surg; 2018 Aug; 85(2):256-262. PubMed ID: 29664891
[TBL] [Abstract][Full Text] [Related]
18. Management of ventilator-associated pneumonia: epidemiology, diagnosis and antimicrobial therapy.
Bassetti M; Taramasso L; Giacobbe DR; Pelosi P
Expert Rev Anti Infect Ther; 2012 May; 10(5):585-96. PubMed ID: 22702322
[TBL] [Abstract][Full Text] [Related]
19. Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: a prospective study.
Michalopoulos A; Fotakis D; Virtzili S; Vletsas C; Raftopoulou S; Mastora Z; Falagas ME
Respir Med; 2008 Mar; 102(3):407-12. PubMed ID: 18060758
[TBL] [Abstract][Full Text] [Related]
20. Intravenous vs intravenous plus aerosolized colistin for treatment of ventilator-associated pneumonia - a matched case-control study in neonates.
Hussain K; Salat MS; Ambreen G; Mughal A; Idrees S; Sohail M; Iqbal J
Expert Opin Drug Saf; 2020 Dec; 19(12):1641-1649. PubMed ID: 32892635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
